Alexandre Pariente

13.2k total citations · 4 hit papers
296 papers, 8.1k citations indexed

About

Alexandre Pariente is a scholar working on Toxicology, Pharmacology and Epidemiology. According to data from OpenAlex, Alexandre Pariente has authored 296 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Toxicology, 44 papers in Pharmacology and 44 papers in Epidemiology. Recurrent topics in Alexandre Pariente's work include Pharmacovigilance and Adverse Drug Reactions (69 papers), Pharmaceutical Practices and Patient Outcomes (37 papers) and Drug-Induced Adverse Reactions (23 papers). Alexandre Pariente is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (69 papers), Pharmaceutical Practices and Patient Outcomes (37 papers) and Drug-Induced Adverse Reactions (23 papers). Alexandre Pariente collaborates with scholars based in France, Italy and United States. Alexandre Pariente's co-authors include Nicholas Moore, Bernard Bégaud, Annie Fourrier‐Réglat, Francesco Salvo, Julien Bezin, Sophie Billioti de Gage, Marie Tournier, Tobias Kurth, R. Lassalle and Patrick Blin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Alexandre Pariente

265 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study

2018 836 citations Alexandre Pariente et al. profile →
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology

2017 398 citations Julien Bezin, Alexandre Pariente et al. profile →
Benzodiazepine use and risk of Alzheimer's disease: case-control study

2014 380 citations Hélène Verdoux, Marie Tournier et al. profile →
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer

2022 184 citations Julien Bezin, Amandine Gouverneur et al. profile →

Peers

Countries citing papers authored by Alexandre Pariente

Since Specialization

Citations

This map shows the geographic impact of Alexandre Pariente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Pariente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Pariente more than expected).

Fields of papers citing papers by Alexandre Pariente

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Pariente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Pariente. The network helps show where Alexandre Pariente may publish in the future.

Co-authorship network of co-authors of Alexandre Pariente

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Pariente. A scholar is included among the top collaborators of Alexandre Pariente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Pariente. Alexandre Pariente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The safety profile of fluoroquinolones 2025 ·Infectious Diseases Now ·A.‐P. Jonville‐Béra, Bérenger Largeau, (unknown), Alexandre Pariente	0
2	Guidelines and Best Practices for the Use of Targeted Maximum Likelihood and Machine Learning When Estimating Causal Effects of Exposures on Time‐To‐Event Outcomes 2025 ·Statistics in Medicine ·Denis Talbot, (unknown), (unknown), Yohann Chiu, Caroline Sirois, Andrew J. Spieker, Alexandre Pariente, Pernelle Noïze, Marc Simard, Miguel Ángel Luque-Fernández, Michael Schomaker, (unknown), Danijela Gnjidic, Mireille E. Schnitzer	1
3	Can requests for real-world evidence by the French HTA body be planned? An exhaustive retrospective case–control study of medicinal products appraisals from 2016 to 2021 2024 ·International Journal of Technology Assessment in Health Care ·(unknown), (unknown), (unknown), (unknown), (unknown), Pierre Cochat, (unknown), Driss Berdaï, Alexandre Pariente, Francesco Salvo, Antoine Vanier	3
4	Réalisation d’études pharmacoépidémiologiques à partir du système national des données de santé (SNDS) : application des recommandations dans la pratique 2023 ·Therapies ·(unknown), (unknown), Joëlle Micallef, (unknown), Laurent Chouchana, Margaux Lafaurie, Alexandre Pariente	4
5	Effects of iloprost in patients with critical limb ischemia: Results of a cohort study from the COPART registry 2023 ·JMV-Journal de Médecine Vasculaire ·(unknown), J. Constans, Carine Boulon, Caroline Caradu, (unknown), A. Bura-Rivière, (unknown), Philippe Lacroix, Julien Bezin, Alexandre Pariente	0
6	Trajectories of Benzodiazepine Use among Older Adults from a Concordance-with-Guidelines Perspective: A Nationwide Cohort Study 2023 ·Drugs & Aging ·Sandy Maumus‐Robert, (unknown), Marie Tournier, Bernard Bégaud, Alexandre Pariente	3
7	Angiodisplasias y telangiectasias digestivas 2023 ·EMC - Tratado de Medicina ·Alexandre Pariente	0
8	Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study 2022 ·European Journal of Epidemiology ·Clément Mathieu, Élodie Pambrun, Anne Bénard‐Laribière, Pernelle Noïze, Jean‐Luc Faillie, Julien Bezin, Alexandre Pariente	15
9	JAK inhibitors and risk of major cardiovascular events or venous thromboembolism: a self-controlled case series study 2022 ·European Journal of Clinical Pharmacology ·Amandine Gouverneur, Jérôme Avouac, Clément Prati, Jean‐Luc Cracowski, Thierry Schaeverbeke, Alexandre Pariente, Marie‐Elise Truchetet	19
10	The risk of dementia in patients using psychotropic drugs: Antidepressants, mood stabilizers or antipsychotics 2021 ·Acta Psychiatrica Scandinavica ·Marie Tournier, Élodie Pambrun, Sandy Maumus‐Robert, Alexandre Pariente, Hélène Verdoux	11
11	Chronic polypharmacy at all age: A population‐based drug utilization study 2021 ·Fundamental and Clinical Pharmacology ·(unknown), Sandy Maumus‐Robert, Alexandre Pariente, Julien Bezin	6
12	Specific features of amoxicillin‐associated Drug Reaction with Eosinophilia and Systemic Symptoms syndrome: a nationwide study 2021 ·Journal of the European Academy of Dermatology and Venereology ·Bérenger Largeau, (unknown), (unknown), Alexandre Pariente, A. Maruani, Thierry Vial, A.‐P. Jonville‐Béra	5
13	Impact of benzodiazepine consumption reduction on future burden of dementia 2020 ·Scientific Reports ·Hélène Jacqmin‐Gadda, (unknown), Clément Mathieu, Catherine Helmer, Alexandre Pariente, Pierre Joly	7
14	Risk of Intracranial Aneurysm and Dissection and Fluoroquinolone Use 2020 ·Stroke ·Sandy Maumus‐Robert, Stéphanie Debette, Xavier Bérard, Yohann Mansiaux, Pascale Tubert‐Bitter, Alexandre Pariente	15
15	Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011–2016 2019 ·BMJ Open ·Géric Maura, Cécile Billionnet, Jérôme Drouin, Alain Weill, Anke Neumann, Alexandre Pariente	46
16	Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in France 2017 ·BMJ Open ·Anne Bénard‐Laribière, Alexandre Pariente, Élodie Pambrun, Bernard Bégaud, L. Fardet, Pernelle Noïze	70
17	How to detect and diagnose an autochthonous hepatitis E 2009 ·Gastroentérologie Clinique et Biologique ·Christophe Renou, (unknown), Alexandre Pariente, (unknown), Nicole Pavio	2
18	Colonoscopic Screening of First-Degree Relatives of Patients With Large Adenomas: Increased Risk of Colorectal Tumors 2007 ·Gastroenterology ·Vanessa Cottet, Alexandre Pariente, Bernard Nalet, (unknown), Chantal Milan, Sylviane Olschwang, Catherine Bonaïti‐Pellié, Jean Faivre, Claire Bonithon‐Kopp	66
19	The use of Atypical antipsychotics in French psychiatric hospitals 2007 ·Pharmacy World & Science ·(unknown), (unknown), Alexandre Pariente, (unknown)	7
20	Hépatites auto-immunes : prise en charge thérapeutique 2003 ·Gastroentérologie Clinique et Biologique ·Alexandre Pariente	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact